NGM·Healthcare·$436M·#213 / 520 in Healthcare
FLGT Fulgent Genetics, Inc.
50SPECULATIVE
CATEGORY BREAKDOWN
GROWTH22
QUALITY37
STABILITY40
VALUATION98
GOVERNANCE100
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+13.8%
22
> 50% strong
Gross Margin
Revenue retained after direct costs
40.6%
56
> 50% strong
Cash Runway
Months of cash at current burn rate
6 months
10
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
0.7%
99
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.4x
98
< 3x strong
Rule of 40
Growth rate plus operating margin
-14
9
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
35.0%
100
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-14.8%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE FLGT WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when FLGT's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.